COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics | COMM | 00461U105 | 4,186 | 1,911,573 | SH | | SOLE | | 1,911,573 | 0 | 0 |
Amarin | ADR | 023111206 | 100,989 | 5,208,305 | SH | | SOLE | | 5,208,305 | 0 | 0 |
Apellis Pharmaceuticals, Inc | COMM | 03753U106 | 1,256 | 49,580 | SH | | SOLE | | 49,580 | 0 | 0 |
Ascendis Pharma A/S | ADR | 04351P101 | 126,645 | 1,099,824 | SH | | SOLE | | 1,099,824 | 0 | 0 |
Audentes Therapeutics | COMM | 05070R104 | 35,348 | 933,640 | SH | | SOLE | | 933,640 | 0 | 0 |
Chiasma | COMM | 16706W102 | 12,178 | 1,630,221 | SH | | SOLE | | 1,630,221 | 0 | 0 |
Coherus BioSciences | COMM | 19249H103 | 46,260 | 2,093,221 | SH | | SOLE | | 2,093,221 | 0 | 0 |
Entasis Therapeutics Holdings Inc. | COMM | 293614103 | 7,612 | 1,180,178 | SH | | SOLE | | 1,180,178 | 0 | 0 |
Iterum Therapeutics | COMM | G6333L101 | 11,878 | 1,726,514 | SH | | SOLE | | 1,726,514 | 0 | 0 |
Karuna Therapeutics, Inc. | COMM | 48576A100 | 34,622 | 1,729,352 | SH | | SOLE | | 1,729,352 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | 12,493 | 922,700 | SH | | SOLE | | 922,700 | 0 | 0 |
Merus N.V. | COMM | N5749R100 | 28,729 | 1,961,039 | SH | | SOLE | | 1,961,039 | 0 | 0 |
Natera | COMM | 632307104 | 85,513 | 3,100,560 | SH | | SOLE | | 3,100,560 | 0 | 0 |
Nextcure, Inc | COMM | 65343E108 | 37,777 | 2,521,856 | SH | | SOLE | | 2,521,856 | 0 | 0 |
Nucana Biomed Ltd | ADR | 67022C106 | 23,528 | 2,266,666 | SH | | SOLE | | 2,266,666 | 0 | 0 |
Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | 24,912 | 2,400,000 | SH | | SOLE | | 2,400,000 | 0 | 0 |
ObsEva SA | COMM | H5861P103 | 53,718 | 4,749,623 | SH | | SOLE | | 4,749,623 | 0 | 0 |
PDS Biotechnology Corporation | COMM | 70465T107 | 854 | 142,635 | SH | | SOLE | | 142,635 | 0 | 0 |
Principia Biopharma | COMM | 74257L108 | 67,648 | 2,038,208 | SH | | SOLE | | 2,038,208 | 0 | 0 |
Spark Therapeutics | COMM | 84652J103 | 49,272 | 481,270 | SH | | SOLE | | 481,270 | 0 | 0 |
Synlogic Inc. | COMM | 87166L100 | 5,232 | 574,972 | SH | | SOLE | | 574,972 | 0 | 0 |
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 48,125 | 2,104,278 | SH | | SOLE | | 2,104,278 | 0 | 0 |
ACADIA Pharmaceuticals Inc | COMM | 004225108 | 1,493 | 55,850 | SH | | SOLE | | 55,850 | 0 | 0 |
AbbVie Inc | COMM | 00287Y109 | 753 | 10,352 | SH | | SOLE | | 10,352 | 0 | 0 |
Acceleron Pharma Inc | COMM | 00434H108 | 3,570 | 86,908 | SH | | SOLE | | 86,908 | 0 | 0 |
Acorda Therapeutics Inc | COMM | 00484M106 | 537 | 70,066 | SH | | SOLE | | 70,066 | 0 | 0 |
Adverum Biotechnologies Inc | COMM | 00773U108 | 802 | 67,444 | SH | | SOLE | | 67,444 | 0 | 0 |
Akebia Therapeutics Inc | COMM | 00972D105 | 1,475 | 304,787 | SH | | SOLE | | 304,787 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 5,103 | 30,481 | SH | | SOLE | | 30,481 | 0 | 0 |
Allergan plc | COMM | G0177J908 | 3,014 | 18,000 | SH | Call | SOLE | | 18,000 | 0 | 0 |
Alnylam Pharmaceuticals Inc | COMM | 02043Q107 | 725 | 9,994 | SH | | SOLE | | 9,994 | 0 | 0 |
Amgen Inc | COMM | 031162950 | 3,317 | 18,000 | SH | Put | SOLE | | 18,000 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 3,032 | 242,971 | SH | | SOLE | | 242,971 | 0 | 0 |
Applied Therapeutics Inc | COMM | 03828A101 | 415 | 50,350 | SH | | SOLE | | 50,350 | 0 | 0 |
ArQule Inc | COMM | 04269E107 | 1,114 | 101,215 | SH | | SOLE | | 101,215 | 0 | 0 |
Autolus Therapeutics PLC | ADR | 05280R100 | 380 | 23,616 | SH | | SOLE | | 23,616 | 0 | 0 |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 583 | 153,942 | SH | | SOLE | | 153,942 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 2,572 | 30,029 | SH | | SOLE | | 30,029 | 0 | 0 |
Bristol-Myers Squibb Co | COMM | 110122908 | 1,628 | 35,900 | SH | Call | SOLE | | 35,900 | 0 | 0 |
Bristol-Myers Squibb Co | COMM | 110122108 | 2,828 | 62,368 | SH | | SOLE | | 62,368 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 741 | 190,075 | SH | | SOLE | | 190,075 | 0 | 0 |
Clovis Oncology Inc | COMM | 189464100 | 669 | 44,966 | SH | | SOLE | | 44,966 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T951 | 810 | 35,900 | SH | Put | SOLE | | 35,900 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 2,263 | 236,746 | SH | | SOLE | | 236,746 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 973 | 408,895 | SH | | SOLE | | 408,895 | 0 | 0 |
Forty Seven Inc | COMM | 34983P104 | 452 | 42,665 | SH | | SOLE | | 42,665 | 0 | 0 |
Halozyme Therapeutics Inc | COMM | 40637H109 | 4,200 | 244,475 | SH | | SOLE | | 244,475 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 4,134 | 222,360 | SH | | SOLE | | 222,360 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 2,124 | 24,998 | SH | | SOLE | | 24,998 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X901 | 819 | 63,100 | SH | Call | SOLE | | 63,100 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 588 | 45,291 | SH | | SOLE | | 45,291 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,601 | 777,390 | SH | | SOLE | | 777,390 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 671 | 105,105 | SH | | SOLE | | 105,105 | 0 | 0 |
MacroGenics Inc | COMM | 556099109 | 3,360 | 197,969 | SH | | SOLE | | 197,969 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 3,315 | 34,528 | SH | | SOLE | | 34,528 | 0 | 0 |
Neurocrine Biosciences Inc | COMM | 64125C109 | 4,721 | 55,921 | SH | | SOLE | | 55,921 | 0 | 0 |
Novo Nordisk A/S | ADR | 670100205 | 5,931 | 116,204 | SH | | SOLE | | 116,204 | 0 | 0 |
Orchard Therapeutics PLC | ADR | 68570P101 | 1,795 | 128,298 | SH | | SOLE | | 128,298 | 0 | 0 |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 707 | 186,030 | SH | | SOLE | | 186,030 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 1,287 | 467,940 | SH | | SOLE | | 467,940 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 5,984 | 132,983 | SH | | SOLE | | 132,983 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 3,931 | 41,660 | SH | | SOLE | | 41,660 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 812 | 87,170 | SH | | SOLE | | 87,170 | 0 | 0 |
TG Therapeutics Inc | COMM | 88322Q108 | 3,924 | 453,638 | SH | | SOLE | | 453,638 | 0 | 0 |
Uniqure NV | COMM | N90064101 | 1,407 | 18,000 | SH | Call | SOLE | | 18,000 | 0 | 0 |
Vertex Pharmaceuticals Inc | COMM | 92532F100 | 3,265 | 17,803 | SH | | SOLE | | 17,803 | 0 | 0 |
XBiotech Inc | COMM | 98400H102 | 903 | 119,117 | SH | | SOLE | | 119,117 | 0 | 0 |
Zogenix Inc | COMM | 98978L904 | 865 | 18,100 | SH | Call | SOLE | | 18,100 | 0 | 0 |
Zymeworks Inc | COMM | 98985W102 | 1,484 | 67,470 | SH | | SOLE | | 67,470 | 0 | 0 |
ACADIA Pharmaceuticals Inc | COMM | 004225108 | 888 | 33,222 | SH | | OTR | 1 | 33,222 | 0 | 0 |
AbbVie Inc | COMM | 00287Y109 | 449 | 6,168 | SH | | OTR | 1 | 6,168 | 0 | 0 |
Acceleron Pharma Inc | COMM | 00434H108 | 2,126 | 51,752 | SH | | OTR | 1 | 51,752 | 0 | 0 |
Acorda Therapeutics Inc | COMM | 00484M106 | 319 | 41,539 | SH | | OTR | 1 | 41,539 | 0 | 0 |
Adverum Biotechnologies Inc | COMM | 00773U108 | 478 | 40,162 | SH | | OTR | 1 | 40,162 | 0 | 0 |
Akebia Therapeutics Inc | COMM | 00972D105 | 878 | 181,392 | SH | | OTR | 1 | 181,392 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 3,026 | 18,076 | SH | | OTR | 1 | 18,076 | 0 | 0 |
Allergan plc | COMM | G0177J908 | 1,792 | 10,700 | SH | Call | OTR | 1 | 10,700 | 0 | 0 |
Alnylam Pharmaceuticals Inc | COMM | 02043Q107 | 432 | 5,952 | SH | | OTR | 1 | 5,952 | 0 | 0 |
Amgen Inc | COMM | 031162950 | 1,953 | 10,600 | SH | Put | OTR | 1 | 10,600 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 1,811 | 145,118 | SH | | OTR | 1 | 145,118 | 0 | 0 |
Applied Therapeutics Inc | COMM | 03828A101 | 250 | 30,324 | SH | | OTR | 1 | 30,324 | 0 | 0 |
ArQule Inc | COMM | 04269E107 | 663 | 60,239 | SH | | OTR | 1 | 60,239 | 0 | 0 |
Autolus Therapeutics PLC | ADR | 05280R100 | 227 | 14,104 | SH | | OTR | 1 | 14,104 | 0 | 0 |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 346 | 91,299 | SH | | OTR | 1 | 91,299 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 1,552 | 18,115 | SH | | OTR | 1 | 18,115 | 0 | 0 |
Bristol-Myers Squibb Co | COMM | 110122908 | 970 | 21,400 | SH | Call | OTR | 1 | 21,400 | 0 | 0 |
Bristol-Myers Squibb Co | COMM | 110122108 | 1,683 | 37,113 | SH | | OTR | 1 | 37,113 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 441 | 113,008 | SH | | OTR | 1 | 113,008 | 0 | 0 |
Clovis Oncology Inc | COMM | 189464100 | 398 | 26,761 | SH | | OTR | 1 | 26,761 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T951 | 483 | 21,400 | SH | Put | OTR | 1 | 21,400 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 1,348 | 140,956 | SH | | OTR | 1 | 140,956 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 549 | 230,742 | SH | | OTR | 1 | 230,742 | 0 | 0 |
Forty Seven Inc | COMM | 34983P104 | 269 | 25,364 | SH | | OTR | 1 | 25,364 | 0 | 0 |
Halozyme Therapeutics Inc | COMM | 40637H109 | 2,532 | 147,379 | SH | | OTR | 1 | 147,379 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 2,461 | 132,387 | SH | | OTR | 1 | 132,387 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 1,264 | 14,878 | SH | | OTR | 1 | 14,878 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X901 | 488 | 37,600 | SH | Call | OTR | 1 | 37,600 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 350 | 26,970 | SH | | OTR | 1 | 26,970 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 966 | 468,954 | SH | | OTR | 1 | 468,954 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 406 | 63,588 | SH | | OTR | 1 | 63,588 | 0 | 0 |
MacroGenics Inc | COMM | 556099109 | 1,999 | 117,813 | SH | | OTR | 1 | 117,813 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 1,973 | 20,546 | SH | | OTR | 1 | 20,546 | 0 | 0 |
Neurocrine Biosciences Inc | COMM | 64125C109 | 2,812 | 33,301 | SH | | OTR | 1 | 33,301 | 0 | 0 |
Novo Nordisk A/S | ADR | 670100205 | 3,528 | 69,122 | SH | | OTR | 1 | 69,122 | 0 | 0 |
Orchard Therapeutics PLC | ADR | 68570P101 | 1,110 | 79,372 | SH | | OTR | 1 | 79,372 | 0 | 0 |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 426 | 112,146 | SH | | OTR | 1 | 112,146 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 781 | 283,853 | SH | | OTR | 1 | 283,853 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 3,564 | 79,193 | SH | | OTR | 1 | 79,193 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 2,341 | 24,809 | SH | | OTR | 1 | 24,809 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 483 | 51,880 | SH | | OTR | 1 | 51,880 | 0 | 0 |
TG Therapeutics Inc | COMM | 88322Q108 | 2,335 | 269,999 | SH | | OTR | 1 | 269,999 | 0 | 0 |
Uniqure NV | COMM | N90064101 | 836 | 10,700 | SH | Call | OTR | 1 | 10,700 | 0 | 0 |
Vertex Pharmaceuticals Inc | COMM | 92532F100 | 1,970 | 10,742 | SH | | OTR | 1 | 10,742 | 0 | 0 |
XBiotech Inc | COMM | 98400H102 | 537 | 70,855 | SH | | OTR | 1 | 70,855 | 0 | 0 |
Zogenix Inc | COMM | 98978L904 | 511 | 10,700 | SH | Call | OTR | 1 | 10,700 | 0 | 0 |
Zymeworks Inc | COMM | 98985W102 | 884 | 40,170 | SH | | OTR | 1 | 40,170 | 0 | 0 |
ACADIA Pharmaceuticals Inc | COMM | 004225108 | 1,778 | 66,504 | SH | | OTR | 2 | 66,504 | 0 | 0 |
AbbVie Inc | COMM | 00287Y109 | 901 | 12,391 | SH | | OTR | 2 | 12,391 | 0 | 0 |
Acceleron Pharma Inc | COMM | 00434H108 | 4,206 | 102,383 | SH | | OTR | 2 | 102,383 | 0 | 0 |
Acorda Therapeutics Inc | COMM | 00484M106 | 632 | 82,431 | SH | | OTR | 2 | 82,431 | 0 | 0 |
Adverum Biotechnologies Inc | COMM | 00773U108 | 945 | 79,453 | SH | | OTR | 2 | 79,453 | 0 | 0 |
Akebia Therapeutics Inc | COMM | 00972D105 | 1,753 | 362,177 | SH | | OTR | 2 | 362,177 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 6,007 | 35,876 | SH | | OTR | 2 | 35,876 | 0 | 0 |
Allergan plc | COMM | G0177J908 | 3,566 | 21,300 | SH | Call | OTR | 2 | 21,300 | 0 | 0 |
Alnylam Pharmaceuticals Inc | COMM | 02043Q107 | 860 | 11,846 | SH | | OTR | 2 | 11,846 | 0 | 0 |
Amgen Inc | COMM | 031162950 | 3,944 | 21,400 | SH | Put | OTR | 2 | 21,400 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 2,436 | 195,220 | SH | | OTR | 2 | 195,220 | 0 | 0 |
Applied Therapeutics Inc | COMM | 03828A101 | 505 | 61,330 | SH | | OTR | 2 | 61,330 | 0 | 0 |
ArQule Inc | COMM | 04269E107 | 1,326 | 120,403 | SH | | OTR | 2 | 120,403 | 0 | 0 |
Autolus Therapeutics PLC | ADR | 05280R100 | 452 | 28,060 | SH | | OTR | 2 | 28,060 | 0 | 0 |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 687 | 181,159 | SH | | OTR | 2 | 181,159 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 3,148 | 36,752 | SH | | OTR | 2 | 36,752 | 0 | 0 |
Bristol-Myers Squibb Co | COMM | 110122908 | 1,936 | 42,700 | SH | Call | OTR | 2 | 42,700 | 0 | 0 |
Bristol-Myers Squibb Co | COMM | 110122108 | 3,373 | 74,368 | SH | | OTR | 2 | 74,368 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 884 | 226,756 | SH | | OTR | 2 | 226,756 | 0 | 0 |
Clovis Oncology Inc | COMM | 189464100 | 797 | 53,576 | SH | | OTR | 2 | 53,576 | 0 | 0 |
Deciphera Pharmaceuticals Inc | COMM | 24344T951 | 965 | 42,800 | SH | Put | OTR | 2 | 42,800 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 2,698 | 282,180 | SH | | OTR | 2 | 282,180 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 1,133 | 476,173 | SH | | OTR | 2 | 476,173 | 0 | 0 |
Forty Seven Inc | COMM | 34983P104 | 538 | 50,774 | SH | | OTR | 2 | 50,774 | 0 | 0 |
Halozyme Therapeutics Inc | COMM | 40637H109 | 5,126 | 298,345 | SH | | OTR | 2 | 298,345 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 4,879 | 262,438 | SH | | OTR | 2 | 262,438 | 0 | 0 |
Incyte Corp | COMM | 45337C102 | 2,526 | 29,736 | SH | | OTR | 2 | 29,736 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X901 | 964 | 74,300 | SH | Call | OTR | 2 | 74,300 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 697 | 53,694 | SH | | OTR | 2 | 53,694 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,973 | 957,858 | SH | | OTR | 2 | 957,858 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 820 | 128,557 | SH | | OTR | 2 | 128,557 | 0 | 0 |
MacroGenics Inc | COMM | 556099109 | 3,982 | 234,661 | SH | | OTR | 2 | 234,661 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 3,943 | 41,061 | SH | | OTR | 2 | 41,061 | 0 | 0 |
Neurocrine Biosciences Inc | COMM | 64125C109 | 5,626 | 66,638 | SH | | OTR | 2 | 66,638 | 0 | 0 |
Novo Nordisk A/S | ADR | 670100205 | 7,062 | 138,371 | SH | | OTR | 2 | 138,371 | 0 | 0 |
Orchard Therapeutics PLC | ADR | 68570P101 | 2,208 | 157,799 | SH | | OTR | 2 | 157,799 | 0 | 0 |
Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | 863 | 227,022 | SH | | OTR | 2 | 227,022 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 1,611 | 585,775 | SH | | OTR | 2 | 585,775 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 7,053 | 156,727 | SH | | OTR | 2 | 156,727 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 4,629 | 49,067 | SH | | OTR | 2 | 49,067 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 965 | 103,679 | SH | | OTR | 2 | 103,679 | 0 | 0 |
TG Therapeutics Inc | COMM | 88322Q108 | 4,652 | 537,747 | SH | | OTR | 2 | 537,747 | 0 | 0 |
Uniqure NV | COMM | N90064101 | 1,665 | 21,300 | SH | Call | OTR | 2 | 21,300 | 0 | 0 |
Vertex Pharmaceuticals Inc | COMM | 92532F100 | 3,990 | 21,756 | SH | | OTR | 2 | 21,756 | 0 | 0 |
XBiotech Inc | COMM | 98400H102 | 1,075 | 141,839 | SH | | OTR | 2 | 141,839 | 0 | 0 |
Zogenix Inc | COMM | 98978L904 | 1,013 | 21,200 | SH | Call | OTR | 2 | 21,200 | 0 | 0 |
Zymeworks Inc | COMM | 98985W102 | 1,769 | 80,417 | SH | | OTR | 2 | 80,417 | 0 | 0 |